As one of the major mechanisms of tumour escape, the establishment of an immunosuppressive tumour microenvironment through the induction of adaptive immune resistance by the activation of PD-1/PD-L1 inhibitory checkpoints has been highlighted recently. This evidence concerns the gene RPL17 and neoplasm.